Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Wework India Management Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Sales showed strong growth with 12,700 desks sold in the latest quarter, up 28% YoY; April was the biggest sales month with 7,500 desks sold without…
23 Sept 2026
Can Fin Homes Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Q1 disbursements grew 29% YoY, with both salaried (21%) and self-employed (44%) segments growing. Key concall takeaways from Can Fin Homes Ltd's Q1 FY27…
23 Sept 2026
E2E Networks Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Profitability and EBITDA margins improved significantly in Q1 FY27, with EBITDA margin expanding to 75.2%, driven by operating leverage and capacity…
23 Sept 2026
Fractal Analytics Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
The AI addressable market is expanding rapidly with companies increasing tech spends from 4.5% to possibly 6% of revenue. Key concall takeaways from Fractal…
23 Sept 2026
CEAT Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
CEAT stand-alone volume growth in Q1 was 13-14% year-on-year. Key concall takeaways from CEAT Ltd's Q1 FY27 earnings call — and how it ranks against sector…
23 Sept 2026
CCL Products (India) Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Capacity utilization is currently around 75%; new capacity additions will be considered once utilization exceeds 75%, typically around 85-90%. Key concall…
23 Sept 2026
Action Construction Equipment Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Defense segment orders received this quarter are small (INR 1-5 crores), with no big order yet. Key concall takeaways from Action Construction Equipment Ltd's…
23 Sept 2026
Zen Technologies Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Anti-drone systems represent a much larger market, potentially running into thousands of crores. Key concall takeaways from Zen Technologies Ltd's Q1 FY27…
23 Sept 2026
Punjab & Sind Bank Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
15,000 crores as of June 30. Key concall takeaways from Punjab & Sind Bank's Q1 FY27 earnings call — and how it ranks against sector peers.
23 Sept 2026
Five-Star Business Finance Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
The company raised close to INR1,000 crores in the last quarter, with liquidity sitting on the balance sheet. Key concall takeaways from Five-Star Business…
23 Sept 2026
KFin Technologies Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Alternatives and wealth management businesses are poised for growth, with alternative investment platform market share nearing 40%. Key concall takeaways from…
23 Sept 2026
LMW Q1 FY27: Order Book ₹3,200 Cr | Arthneeti
Q1 FY27
ATC is scaling up with a significant order book (~₹1,000 crores) and capacity expansion underway with ₹150 crore capex for new facility over 18-24 months. Key…
23 Sept 2026
CreditAccess Grameen Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Retail finance book is scaling up, now constituting 20.6% of AUM, growing due to graduation of high-quality vintage customers. Key concall takeaways from…
23 Sept 2026
IIFL Finance Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Gold loan growth is positive but moderated, growing around 11% quarter-on-quarter, with 5-6% driven by tonnage growth. Key concall takeaways from IIFL Finance…
23 Sept 2026
Piramal Pharma Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Piramal Pharma started FY '27 strong with 17% revenue growth and 72% EBITDA growth YoY, signaling positive momentum. Key concall takeaways from Piramal Pharma…
23 Sept 2026
Acutaas Chemicals Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Profit after tax (PAT) grew 70.4% Y-o-Y in Q1 FY '27, indicating strong earnings momentum. Key concall takeaways from Acutaas Chemicals Ltd's Q1 FY27 earnings…
23 Sept 2026
Bandhan Bank Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Wholesale banking is growing rapidly at about 35-40%, focusing on corporate ecosystem expansion despite lower margins. Key concall takeaways from Bandhan Bank…
23 Sept 2026
Karur Vysya Bank Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Disbursement growth of 45% QoQ in Business Banking Group; revival seen in corporate and institutional loans (6% QoQ). Key concall takeaways from Karur Vysya…
23 Sept 2026
Himadri Speciality Chemical Q1 FY27 earnings call: Revenue & Margins | Arthneeti
Q1 FY27
Planned capex of approximately INR 2,000 Crores over next 2 years to support new energy materials and specialty product expansion. Key concall takeaways from…
23 Sept 2026
360 ONE WAM Q1 FY27: Revenue ₹600 Cr | Arthneeti
Q1 FY27
Distribution assets in the HNI segment growing steadily, from Rs 600 crores to over Rs 5,100-5,200 crores, with revenue recognition lagging by 12 months. Key…
23 Sept 2026